Synapse - Marc Ladanyi

Results (70)

Chromothripsis-mediated small cell lung carcinoma

Journal Article

Rekhtman, N.; Tischfield, S. E.; Febres-Aldana, C. A.; Lee, J. J. K.; Chang, J. C.; Herzberg, B. O.; Selenica, P.; Woo, H. J.; Vanderbilt, C. M.; Yang, S. R.; more...
Cancer Discovery (2025)

Fulltext@MSK | Save

Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma

Journal Article

Zhu, G.; Benayed, R.; Ho, C.; Mullaney, K.; Sukhadia, P.; Rios, K.; Berry, R.; Rubin, B. P.; Nafa, K.; Wang, L.; more...
Modern Pathology (2019)

Fulltext@MSK | Save

YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics

Journal Article

Fan, P. D.; Narzisi, G.; Jayaprakash, A. D.; Venturini, E.; Robine, N.; Smibert, P.; Germer, S.; Yu, H. A.; Jordan, E. J.; Paik, P. K.; more...
Proceedings of the National Academy of Sciences of the United States of America (2018)

Fulltext@MSK | Save

Modeling of oncogenic chromosomal translocations of aggressive fusion-positive sarcomas by CRISPR-Cas9 genomic engineering

Meeting Abstract

Spraggon, L.; Martelotto, L.; Hmeljak, J.; Hitchman, T.; Wang, J.; Wang, L.; Slotkin, E.; Fan, P. D.; Reis-Filho, J.; Ladanyi, M.
Clinical Cancer Research (2018)

Fulltext@MSK | Save

YES1 amplification as a mechanism of acquired resistance (AR) to EGFR tyrosine kinase inhibitors (TKIs) identified by a transposon mutagenesis screen and clinical genomic testing

Meeting Abstract

Fan, P. D.; Narzisi, G.; Jayaprakash, A.; Venturini, E.; Robine, N.; Smibert, P.; Germer, S.; Jordan, E.; Wang, L.; Jungbluth, A. A.; more...
Journal of Clinical Oncology (2017)

Fulltext@MSK | Save

A phase 2 study of cabozantinib for patients with advanced RET-rearranged lung cancers

Meeting Abstract

Drilon, A.; Somwar, R.; Smith, R.; Delasos, L.; Albano, M.; Van Voorthuyson, M.; Wang, L.; Rekhtman, N.; Ni, A.; Plodkowski, A.; more...
Journal of Thoracic Oncology (2017)

Fulltext@MSK | Save

BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology

Journal Article

Chiang, S.; Lee, C. H.; Stewart, C. J. R.; Oliva, E.; Hoang, L. N.; Ali, R. H.; Hensley, M. L.; Arias-Stella, J. A. 3rd; Frosina, D.; Jungbluth, A. A.; more...
Modern Pathology (2017)

Fulltext@MSK | Save

Chromosome 20q amplification defines a subtype of microsatellite stable, left-sided colon cancers with wild-type RAS/RAF and better overall survival

Journal Article

Ptashkin, R. N.; Pagan, C.; Yaeger, R.; Middha, S.; Shia, J.; O'Rourke, K. P.; Berger, M. F.; Wang, L.; Cimera, R.; Wang, J.; more...
Molecular Cancer Research (2017)

Fulltext@MSK | Save

Identification of NTRK3 fusions in childhood melanocytic neoplasms

Journal Article

Wang, L.; Busam, K. J.; Benayed, R.; Cimera, R.; Wang, J.; Denley, R.; Rao, M.; Aryeequaye, R.; Mullaney, K.; Cao, L.; more...
Journal of Molecular Diagnostics (2017)

Fulltext@MSK | Save

Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial

Journal Article

Drilon, A.; Rekhtman, N.; Arcila, M.; Wang, L.; Ni, A.; Albano, M.; Van Voorthuysen, M.; Somwar, R.; Smith, R. S.; Montecalvo, J.; more...
Lancet Oncology (2016)

Fulltext@MSK | Save